Refine my results

Reduced Expression of Cyclooxygenase-2 in Primary Breast Cancer

Boneberg, Eva-Maria ; Legler, Daniel F. ; Senn, Hans-Jörg ; Fürstenberger, Gregor

In: Journal of the National Cancer Institute, 2008, vol. 100, no. 14, p. 1042-1043

Bevacizumab specifically decreases elevated levels of circulating KIT+CD11b+ cells and IL-10 in metastatic breast cancer patients

Cattin, Sarah ; Fellay, Benoît ; Pradervand, Sylvain ; Trojan, Andreas ; Ruhstaller, Thomas ; Rüegg, Curzio ; Fürstenberger, Gregor

In: Oncotarget, 2016, vol. 7, no. 10, p. 11137–11150

Whether bevacizumab exerts its anti-tumor properties through systemic effects beyond local inhibition of angiogenesis and how these effects can be monitored in patients, remain largely elusive. To address these questions, we investigated bone marrow-derived cells and cytokines in the peripheral blood of metastatic breast cancer patients undergoing therapy with...